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strong primary care and patients’ 
survival
Michel Wensing  1, Joachim szecsenyi2, petra Kaufmann-Kolle3 & Gunter Laux4
primary healthcare is the cornerstone of any healthcare system. A major health system reform to 
strengthen primary care has been implemented in Germany since 2008. Key components include: 
voluntary participation, intensive management of patients with chronic diseases, coordination of 
access to medical specialists, continuous quality improvement, and capitation-based reimbursement. 
The objective of this study was to assess the effect of this reform on survival of enrolled patients. We 
conducted a comparative cohorts study with 5-year follow-up, starting in the year 2012 in Baden-
Wuerttemberg, Germany. Participants were 1,003,336 enrolled patients and 725,310 control patients. 
A Cox proportional hazards regression model was applied to compare survival of enrolled patients 
with a composed control cohort of non-enrolled patients, adjusted for a range of patient and physician 
characteristics. Average age of enrolled patients was 57.3 years and 56.1% were women. Compared to 
control patients, they had lower mortality (Hazard Ratio: 0.978; 95% CI: 0.968; 0.989). Participation in 
chronic disease management programs had independent impact on survival rate (Hazard Ratio 0.744, 
95% CI: 0.734; 0.753). We concluded that strong primary care is safe and potentially beneficial in terms 
of patients’ survival.
Strong primary care is characterized by the provision first point of access to healthcare for most people and 
most health issues, high continuity over time and coordination across healthcare providers, and a strong 
patient-centered approach1. Although insight into the causal mechanisms is limited, epidemiological studies 
reported on better health outcomes and lower healthcare costs in healthcare systems with strong primary care2,3. 
Despite these benefits, primary care is under pressure across the world, indicated by shortages of primary care 
capacity and signals of suboptimal performance. Addressing these challenges is therefore high on the political 
agenda4,5.
In Germany, health system reforms to strengthen primary care (‘Hausarztzentrierte Versorgung’) have been 
implemented in the law (Social Code Book V) in the previous decade. These reforms were designed as volun-
tary contracts between healthcare insurers and primary care physicians, and voluntary enrollment by patients. 
These have effectively reformed the healthcare system as they scaled-up intensive management of chronically ill 
patients, coordination of access to medical specialist care, and participation of primary care physicians in con-
tinuous quality improvement activities. Studies reported that these programs increased patients’ use of primary 
care6, reduced number of hospital admissions7 and healthcare costs8. The aim of this study was to assess the effects 
of the strong primary care model on patient survival.
Results
Description of data. Data on 1,003,336 enrolled patients and 725,310 control patients were available 
(Table 1). In the population of enrolled patients, the mean age was 57.3 (SD 18.7) years and 56.1% were women. 
83.4% had the German nationality, 36.6% were retired, and the mean Charlson-Index for co-morbidity was 1.45. 
Enrolled patients had been on average nearly 6 years in the program, meaning from one year before start of the 
observation period of this study. The cohort of non-enrolled patients had slightly different descriptive features, for 
instance younger average age (54.4 years) and fewer co-morbidities (mean Charlson-Index 1.14).
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Healthcare utilization. The mean number of yearly contacts in primary care was 13.65, while the number 
of uncoordinated contacts with medical specialists was 2.06. The average number of hospital admissions per 100 
enrolled patients was 29.0 and the average yearly medication costs were 1452 euro. Control patients had partly 
different healthcare utilization, most particularly fewer yearly contacts in primary care (9.01 on average) and 
more uncoordinated contacts with medical specialists (3.37).
survival. Figure 1 presents the survival rates of enrolled and non-enrolled patients. Compared to control 
patients, enrolled patients in the program had lower mortality (Hazard Ratio: 0.978; 95% CI: 0.968; 0.989). Table 2 
presents which factors were associated with survival. Participation in disease management programs had inde-
pendent positive impact on survival (Hazard Ratio 0.744, 95% CI: 0.734; 0.753). An estimated total number of 
1,672 lives was saved in the strong primary care arm.
Discussion
This study in routine healthcare found lower 5-year mortality in patients enrolled in strong primary care as com-
pared to a comparable cohort of non-enrolled patients. Although the small effect should be carefully interpreted, 
given the non-randomized study design, it was found in a large population in a naturalistic setting and adjusted 
for many potential confounders. The descriptive data on healthcare utilization suggest that the healthcare delivery 
model was successfully implemented in enrolled patients. Overall, the study shows that the strong primary care 
Intervention cohort Control cohort P-Value
Absolute numbers 1,003,336 725,310 n.a.
Mean age (SD) 57.3 (18.7) 54.4 (19.8) p < 0.0001
Gender
-%women 56.1 56.2 n.s.
Nationality
-%German 83.4 81.0 p < 0.0001
Insurance
-%Member
-%Family
-%Retired
52.9
11.6
36.6
54.2
13.7
32.1
p < 0.0001
Comorbidity
-Mean Charlson Index (SD) 1.45 (2.10) 1.14 (1.85) p < 0.0001
Mean number of quarter years in strong primary 
care program (SD) 23.3 (8.6) 0 n.a.
Mean number of contacts in primary care (SD) 13.65 (11.86) 9.01 (11.08) p < 0.0001
Mean number of uncoordinated contacts with 
medical specialists (SD) 2.06 (7.99) 3.37 (9.60) p < 0.0001
Hospital admissions per 100 patients (SD) 29.0 (79.5) 28.6 (79.1) p < 0.001
Costs of ambulatory prescribed medication (SD) 1,452.35 (72,751.71) 1,451.63 (64,450.69) p < 0.001
Table 1. Description of patient cohorts. Legend. All figures on this closed cohort refer to the last year of 
observation.
Figure 1. Survival rates, unadjusted.
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model (including a change to capitation-based reimbursement and structured management patients with chronic 
diseases) was safe and potentially beneficial in terms of patients’ survival.
Strengths of the study are the inclusion of the total eligible and large study population, the naturalistic setting, 
and extensive adjustment for potential confounders in the analysis. The influence of patient self-selection was 
reduced by composing a control cohort on the basis of patients from non-participating physicians; these patients 
did not have the option to enroll. However, the influence of physician self-selection cannot be ruled out. As the 
observation period started four years after initiation of the program and high numbers of physicians have joined 
the healthcare delivery model, it seems plausible that not only early adopters of the innovative program had 
joined.
Evaluation of the patient-centred medical home, a healthcare delivery model which has many features of 
strong primary care, found increased quality of chronic disease care and reduced overall healthcare utilization 
and costs3,9. It seems to comprise many components of strong primary care10. This study confirms these findings 
in a healthcare system, which shares several features with the healthcare system in the United States. Our study 
suggested that participation in disease management – one component of strong primary care - was associated 
with higher survival. While this subgroup effect should be interpreted carefully, it is supported by a substantial 
body of research in primary care11. The relatively high number of patients’ yearly number of contacts in pri-
mary care may facilitate various beneficial activities, such as screening for health problems, monitoring of diag-
nosed diseases, psychosocial support, and intensive care after hospital discharge. Nevertheless, further research is 
needed to provide insight into the working mechanisms in strong primary care.
Methods
study design. The study is based on the total population of enrolled patients and a composed comparison 
cohort in Baden-Wuerttemberg, a state in South-West Germany with about 11 million inhabitants and high 
enrollment in the strong primary care program. The study has a longitudinal, comparative observational design 
with five years of follow-up. It was based on routinely recorded data from ambulatory medical practice, derived 
from administrative databases of the largest regional health insurer and partner of the program (AOK Baden 
Wuerttemberg). It provides health insurance to about 4.4 million individuals; almost 1.5 million of them and 
about 4.000 primary care physicians were enrolled in the strong primary care model in 2016. These patients 
were compared with a composed cohort of non-enrolled patients from the same state. The Heidelberg University 
Hospital Ethics Committee approved the study (No. S-359/2013) and the study was conducted to relevant regula-
tions and methodological guidance. The presented data and interpretations are a very small part of a comprehen-
sive evaluation report12 and a summary version13 in the German language. The STROBE reporting guideline for 
cohort studies was followed in preparing this manuscript.
study population. Eligible were individuals aged 18 years or older, living in Baden-Wuerttemberg, at least 
one visit to the primary care physician in the year of enrollment, health insurance with AOK, no enrollment 
in other integrated care programs. Patients enter or (after one year) leave the program as they wish. They were 
included in the intervention arm if they were registered at start of observation (the year 2012) and remained 
included (without interruptions) until death or end of observation five years later (the year 2016). Patients 
enrolled in the program provided informed consent before participation. They were compared with a control 
cohort, comprising of eligible patients in the observed years in the same state and health insurer, who were linked 
to physicians who did not participate in the program (thus, control patients never had to opportunity to decide on 
participation). These control patients were linked post-hoc to the primary care physician, whom they had visited 
in at least 50% of their contacts in primary care. If no such linkage was possible, they were excluded from analysis.
primary care model. Enrollment in the healthcare delivery model is a free choice for both patients and 
physicians. The physician receives additional secured reimbursement for each enrolled patient (capitation instead 
of fee-for-service). Key component of the program include: improved access to primary care for patients (shorter 
waiting times, absence of out-of-pocket payment for medication); more comprehensive coverage through 
extended medical training by physicians; gate-keeping in access to secondary care; improved information trans-
fer between primary and secondary care; structured disease-management for diabetes, asthma/COPD, coronary 
heart disease run in the primary care practices; continued medical education is coordinated and independent of 
industry; data-drive quality improvement; and use computerized decision support for drug prescribing. Details 
of the program have been described elsewhere6.
Hazard Ratio [95% CI]
Participation in strong primary care delivery model 0.978 [0,968; 0,989]
Sex 1.528 [1.512; 1.544]
Age (in years) 1.076 [1.075; 1.076]
Charlson-Index for co-morbidity 1.213 [1.210; 1.215]
Participation in disease management program 0.744 [0.734; 0.753]
Externally determined need for nursing 1.955 [1.943; 1.968
Living in nursing home 1.109 [1.089; 1.129]
Living in city (as opposed to rural area) 1.023 [1.013; 1.034]
Table 2. Predictors of 5-year mortality, adjusted (n = 1, 373, 911).
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Measures. The primary outcome in this study was overall survival of patients as documented in the admin-
istrative database of the health insurer in the years 2012 to 2016. Patient age, sex, urbanity, recorded morbidities, 
nursing need, nursing home were documented. The Charlson-Index was calculated to summarize comorbidity14. 
We also documented selected indicators of the fidelity of the healthcare delivery model: numbers of contacts in 
primary medical care, non-coordinated contacts with medical specialists, hospital admissions, and costs of ambu-
latory prescribed medication. All measures were based on data in administrative databases and similarly defined 
as in previous evaluations6,7.
Data-analysis. Differences between the two cohorts (presented in Table 1) were statistically tested. The 
statistical analysis focused on the comparison of survival rates between the intervention and control cohorts, 
using Cox proportional hazards regression models. Given the self-selection of physicians and patients into the 
intervention arm, we first identified predictors of physician participation (considering age, gender, urban/rural, 
practice size) and predictors of patient participation (considering age, gender, urban/rural, Charlson-Index, and 
participation in disease management programs) in (separate) logistic regression analyses. Baseline predictors 
with significant impact (P < 0.01, two-sided test) were included in the primary analysis as co-variables. It may be 
noted that statistically significant between-group differences at baseline do not necessarily imply confounding in 
the estimation of intervention effectiveness, because the variables may not be prognostic for outcomes15. In order 
to check the proportional hazards assumption16, the ASSESS-statement of SAS procedure PHREG17 was used; this 
showed that it was fulfilled. In the final regression models, effects were expressed with 95% confidence intervals. 
The Population Attributable Fraction (PAF)18 was used to calculate “saved lives” within the observation period, 
adjusted for confounders. PAF is the estimated fraction of all cases that would have occurred (death) if there had 
been no enrolment in the strong primary care program, adjusted for measured confounders. The analyses were 
performed using SAS 9.4 (SAS Institute Inc., Cary, North Carolina, USA).
ethics approval. Ethics approval was provided by the Heidelberg University Hospital Ethics Committee (No. 
S-359/2013).
Data Availability
AOK Baden-Wuerttemberg can be contacted for secondary analyses of their administrative data.
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